Filing metadata

Accession number
0001104659-17-058897
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Sep 26, 2017
Reporting period
Sep 22, 2017
Description
Insider transaction

Explore SEC Filings Hub